• Lechleiter points to Arxxant, an experimental treatment for some complications of diabetes, as one potential winner.

    FORBES: Magazine Article

  • Lechleiter is chairman, president, and chief executive officer of Eli Lilly and Company.

    FORBES: Move up http://i.forbesimg.com t Move down

  • "We think very highly of ImClone's groundbreaking work in oncology, " Lilly Chief Executive JohnLechleiterJohn Lechleiter said in a prepared statement.

    FORBES: Icahn Wins, But Bristol Isn't A Total Loser Either

  • Lechleiter is the Chairman, President, and CEO of Eli Lilly and Company.

    FORBES: How We Can Pick Up The Pace In The Race To Cure Cancer

  • The promotion marks Lechleiter as a likely successor to Lilly Chairman and Chief Executive SidneyTaurelSidney Taurel, who has headed the company since 1999.

    FORBES: Magazine Article

  • Indeed, Lechleiter says, the company has several other drugs that could compete in the cardiovascular arena, one of the biggest markets in the drug industry.

    FORBES: Magazine Article

  • Eli Lilly announced Tuesday that it has promoted JohnLechleiterJohn Lechleiter, who joined the company as an organic chemist in 1979, to president and chief operating officer.

    FORBES: Magazine Article

  • Lechleiter also notes that the company has settled the majority of product liability suits from patients who say they were not adequately warned that Zyprexa might cause diabetes.

    FORBES: Magazine Article

  • Eli Lilly announced Tuesday that it has promoted John Lechleiter , who joined the company as an organic chemist in 1979, to president and chief operating officer.

    FORBES: Eli Lilly's Next CEO?

  • John Lechleiter, chairman of the trade group Pharmaceutical Research and Manufacturers of America and CEO of Lilly, said Monday that the new program will supplement Interpol's existing efforts.

    NPR: Drugmakers, Interpol Ramp Up Fight Against Fakes

  • D. in organic chemistry from Harvard, Lechleiter said that the company would have no comment--and that his next job would almost certainly depend on how he performed in his new role.

    FORBES: Magazine Article

  • Lechleiter, however, sees no ambiguity in the results.

    FORBES: Magazine Article

  • The promotion marks Lechleiter as a likely successor to Lilly (nyse: LLY - news - people ) Chairman and Chief Executive Sidney Taurel , who has headed the company since 1999.

    FORBES: Eli Lilly's Next CEO?

  • As a result, one thrust of the program will be to try to more quickly spot new trends in which drugs are being counterfeited, where the crime rings are based and where they are distributing fake medicines, Lechleiter said.

    NPR: Drugmakers, Interpol Ramp Up Fight Against Fakes

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定